OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Additional Exclusions of ROS1 Fusions (In Addition to EGFR Mutation and ALK Fusions) in the Cemiplimab NSCLC FDA Indication (EMPOWER-Lung 1 and -Lung 3). Catching Up with Current Scientific View of Immunotherapy in Never-Smoker Predominant Actionable Driver Mutation Positive NSCLC?
Danielle Brazel, Sai‐Hong Ignatius Ou
Lung Cancer Targets and Therapy (2023) Vol. Volume 14, pp. 63-69
Open Access | Times Cited: 3
Danielle Brazel, Sai‐Hong Ignatius Ou
Lung Cancer Targets and Therapy (2023) Vol. Volume 14, pp. 63-69
Open Access | Times Cited: 3
Showing 3 citing articles:
Advancements in NSCLC
Jianan Xu, Lin Tian, Wenlong Qi, et al.
American Journal of Clinical Oncology (2024)
Open Access | Times Cited: 5
Jianan Xu, Lin Tian, Wenlong Qi, et al.
American Journal of Clinical Oncology (2024)
Open Access | Times Cited: 5
LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC
Alexandria TM Lee, Sai‐Hong Ignatius Ou
Lung Cancer Targets and Therapy (2024) Vol. Volume 15, pp. 75-80
Open Access | Times Cited: 1
Alexandria TM Lee, Sai‐Hong Ignatius Ou
Lung Cancer Targets and Therapy (2024) Vol. Volume 15, pp. 75-80
Open Access | Times Cited: 1
ATTLAS, IMpower151 and ORIENT-31: Dusting off IMpower150 for Post-Osimertinib in EGFR-Mutated NSCLC?
Jii Bum Lee, Sai‐Hong Ignatius Ou
Lung Cancer Targets and Therapy (2024) Vol. Volume 15, pp. 81-85
Open Access | Times Cited: 1
Jii Bum Lee, Sai‐Hong Ignatius Ou
Lung Cancer Targets and Therapy (2024) Vol. Volume 15, pp. 81-85
Open Access | Times Cited: 1
